Tango Therapeutics, Inc. (TNGX)

USD 2.79

(-4.12%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 36.52 Million 24.86 Million 37.04 Million 7.65 Million 24.64 Million
Cost of Revenue 115.19 Million 4.02 Million 1.96 Million 1.62 Million 32.27 Million
Gross Profit -78.67 Million 20.83 Million 35.07 Million 6.03 Million -7.62 Million
Operating Expenses 150.7 Million 135.93 Million 95.23 Million 59.85 Million 7.15 Million
Selling, General and Administrative Expenses 35.5 Million 30.02 Million 17.59 Million 9.86 Million 7.53 Million
Research and Development Expenses 115.19 Million 105.9 Million 77.63 Million 49.99 Million 32.27 Million
Other Expenses - 2.94 Million 247 Thousand 120 Thousand -
Cost and Expenses 150.7 Million 135.93 Million 95.23 Million 59.85 Million 39.42 Million
Operating Income -114.17 Million -111.07 Million -58.19 Million -52.2 Million -15.16 Million
Interest Expense - - - - -
Income Tax Expense 134 Thousand 54 Thousand 292 Thousand -108 Thousand -
Earnings before Tax -101.61 Million -108.12 Million -57.94 Million -51.97 Million -14.09 Million
Net Income -101.74 Million -108.17 Million -58.23 Million -51.86 Million -14.09 Million
Earnings Per Share Basic -1.08 -1.23 -0.94 -1.62 -1.57
Earnings Per Share Diluted -1.08 -1.23 -0.94 -1.62 -1.57
Weighted Average Shares Outstanding 94.57 Million 87.82 Million 62.1 Million 31.93 Million 8.98 Million
Weighted Average Shares Outstanding (Diluted) 94.57 Million 87.82 Million 62.1 Million 31.93 Million 8.98 Million
Gross Margin -2.15 0.84 0.95 0.79 -0.31
EBIT Margin -3.06 -4.47 -1.57 -6.72 -0.59
Profit Margin -2.79 -4.35 -1.57 -6.77 -0.57
EBITDA -111.75 Million -109.46 Million -57.29 Million -51.48 Million -14.51 Million
Earnings Before Tax Margin -3.13 -4.47 -1.57 -6.82 -0.62

Income Statement Charts